Clinical practice guidelines for management of medullary thyroid carcinoma: An AGREE II appraisal

Fritz, Christian; Ravin, Emma De; Suresh, Neeraj; Romeo, Dominic; Shah, Mitali; Rajasekaran, Karthik

doi:10.1016/j.amjoto.2022.103606

Cited by 8 publications

(5 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionsupporting

confidence: 79%

“…The findings in this study are in accordance with previous literature utilizing the AGREE II instrument to assess CPGs for a wide variety of interdisciplinary topics involving otolaryngology. [27][28][29] In reviewing 22 CPGs encompassing both RAI indications in DTC as well as the diagnosis and treatment of RAI-R DTC, we sought to complete one of the largest AGREE II guideline evaluations to date on a single topic. Overall, a significant proportion (in this study 90.9%) of guidelines did not meet the "high quality" threshold of >60% in 5 or more domains of quality, indicating substantial shortcomings in the developmental process.…”

Section: Discussionmentioning

confidence: 99%

“…The Appraisal of Guidelines Research and Evaluation (AGREE II) tool is an effective tool for assessing the quality of CPGs 26 . In otorhinolaryngology, the literature has assessed CPGs for a variety of conditions ranging from medullary thyroid carcinoma to evaluation of neck masses, and temporomandibular joint disorder 27‐29 . In this study we sought to (1) conduct a systematic review of all CPGs related to RAI indications in DTC and (2) comprehensively evaluate the development process and methodological quality of these guidelines using the AGREE II instrument.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal

Monos,

Fritz,

Harris

et al. 2023

Otolaryngol.--head neck surg.

Self Cite

View full text Add to dashboard Cite

ObjectiveIdentify and appraise clinical practice guidelines (CPGs) for radioactive iodine (RAI) indications in differentiated thyroid carcinoma (DTC), and the treatment for radioactive iodine refractory (RAI‐R) DTC using the Appraisal of Guidelines for Research and Evaluation II tool.Data SourcesMEDLINE (Pubmed), Ovid (EMBASE), and Scopus.Review MethodsA systematic literature search was conducted to identify CPGs addressing RAI in DTC. CPGs were appraised by 4 independent reviewers in 6 distinct areas of quality. Scaled domain scores were subsequently calculated for each domain. Intraclass correlation coefficients were calculated for each domain to assess interrater reliability.ResultsSixteen guidelines were found addressing RAI indications for DTC. Of these 16, 9 also addressed the treatment of RAI‐R DTC. A further 6 unique guidelines were identified that exclusively address RAI‐R DTC, bringing the total number of guidelines to 22. The American Thyroid Association (ATA) guidelines for adult thyroid cancer were the highest scoring with a mean score of 83.5%. Two guidelines scored >60% in 5 or more domains, qualifying as “high” quality: ATA and British Thyroid Association. The highest scoring domain was domain 4: clarity of presentation (80.4%) while the lowest scoring domain was domain 5: applicability (38.6%).ConclusionOf the 22 guidelines identified, only two were “high quality.” CPGs exclusively addressing the treatment of RAI‐R DTC were weak with most guidelines scoring in the “low” quality range. This report reveals an unmet need for rigorously developed guidelines addressing indications for RAI in DTC, as well as the treatment for RAI‐R DTC.

show abstract

Section: Discussionsupporting

confidence: 79%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal

Monos,

Fritz,

Harris

et al. 2023

Otolaryngol.--head neck surg.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Systematic appraisal of clinical guidelines using the AGREE II instrument has become increasingly employed to illustrate the need for rigorous, high‐quality guidelines across specialties. In the field of otolaryngology, prior studies have assessed CPGs for a variety of clinical scenarios including Meniere's disease, posttonsillectomy pain, and medullary thyroid carcinoma 23‐25 . In this study, we sought to (1) conduct a systematic review of all CPGs related to difficult airway management and (2) comprehensively evaluate the development process and methodological quality of those guidelines using the AGREE II instrument.…”

mentioning

confidence: 99%

“…In the field of otolaryngology, prior studies have assessed CPGs for a variety of clinical scenarios including Meniere's disease, posttonsillectomy pain, and medullary thyroid carcinoma. [23][24][25] In this study, we sought to (1) conduct a systematic review of all CPGs related to difficult airway management and (2) comprehensively evaluate the development process and methodological quality of those guidelines using the AGREE II instrument. We expect this endeavor to yield targeted recommendations for the improvement of future guidelines.…”

mentioning

confidence: 99%

Management of the Difficult Airway: An Appraisal of Clinical Practice Guidelines

Fritz

Monos

et al. 2023

Otolaryngol.--head neck surg.

Self Cite

View full text Add to dashboard Cite

ObjectiveManagement of the difficult airway can be a challenging process, which necessitates actionable recommendations from well‐established guidelines. Herein, clinical practice guideline (CPG) quality is evaluated using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.Study DesignA systematic literature search was performed using Scopus, EMBASE, and MEDLINE via PubMed.SettingLiterature database.MethodsData were abstracted from relevant guidelines and appraised by 4 expert reviewers in the 6 domains of quality defined by AGREE II. Intraclass correlation coefficients (ICC) were calculated across domains to quantify interrater reliability.ResultsTwelve guidelines met the inclusion criteria. With a mean quality score of 83.1%, the highest quality guideline was authored by the American Society of Anesthesiologists (ASA). Low‐quality content was observed in CPGs authored by the Japanese Society of Anesthesiologists (JSA) and the Chinese Collaboration Group for Emergency Airway Management (CCGEAM). Overall, deficits were most pronounced in domains describing the involvement of stakeholders, developmental rigor, and editorial independence. These findings were consistent among the panel of independent reviewers, with high ICC inter‐rater reliability scores of 58.0% to 70.0% for the referenced domains.ConclusionBy providing a comprehensive appraisal of guidelines, this report may serve as a reference for clinicians seeking to understand and improve upon the developmental quality of difficult airway management resources. According to AGREE II criteria for the quality of the guideline creation process, the 2022 ASA guideline outperforms its predecessors.

show abstract

Clinical practice guidelines for management of head and neck squamous cell carcinoma of unknown primary: an AGREE II appraisal

Fritz

Harris

et al. 2023

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Clinical practice guidelines for management of medullary thyroid carcinoma: An AGREE II appraisal

Cited by 8 publications

References 33 publications

Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal

Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal

Management of the Difficult Airway: An Appraisal of Clinical Practice Guidelines

Clinical practice guidelines for management of head and neck squamous cell carcinoma of unknown primary: an AGREE II appraisal

Contact Info

Product

Resources

About